nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells
|
Rushworth, Stuart A |
|
2015 |
2 |
5 |
p. e204-e211 nvt p. |
artikel |
2 |
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis
|
Admiraal, Rick |
|
2015 |
2 |
5 |
p. e194-e203 nvt p. |
artikel |
3 |
ATG in paediatric haemopoietic stem cell transplantation
|
Diaz, Miguel A |
|
2015 |
2 |
5 |
p. e178-e179 nvt p. |
artikel |
4 |
Chronic myeloid leukaemia: time to push for a cure?
|
The Lancet Haematology, |
|
2015 |
2 |
5 |
p. e175- 1 p. |
artikel |
5 |
Clinical associations of CSNK1A1 mutation in myelodysplastic syndrome
|
Boultwood, Jacqueline |
|
2015 |
2 |
5 |
p. e182-e183 nvt p. |
artikel |
6 |
CML and tyrosine kinase inhibition: the hope becomes reality
|
Apperley, Jane F |
|
2015 |
2 |
5 |
p. e176-e177 nvt p. |
artikel |
7 |
Correction to Lancet Haematol 2015; 2: e93
|
|
|
2015 |
2 |
5 |
p. e184- 1 p. |
artikel |
8 |
CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis
|
Smith, Alexander E |
|
2015 |
2 |
5 |
p. e212-e221 nvt p. |
artikel |
9 |
Ibrutinib for AML? Check CD117 (KIT)!
|
Spaargaren, Marcel |
|
2015 |
2 |
5 |
p. e180-e181 nvt p. |
artikel |
10 |
Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials
|
Sasaki, Koji |
|
2015 |
2 |
5 |
p. e186-e193 nvt p. |
artikel |
11 |
55th Annual Scientific Meeting of the BSH
|
Yaqub, Farhat |
|
2015 |
2 |
5 |
p. e185- 1 p. |
artikel |